Antifungal activity of SN 105-843 gel in vivo.
D000499:Allylamine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000588:Amines / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D004341:Drug Evaluation; D005782:Gels; D006801:Humans
D000588:Amines; D000935:Antifungal Agents; D005782:Gels; D000499:Allylamine; C029178:naftifine